U-M Rogel Cancer Center

@UMRogelCancer

The University of Michigan Rogel Cancer Center is committed to improving the health and well-being of people with cancer. Part of @umichmedicine. #GoBlue

Ann Arbor, MI

Joined July 2011

2KFollowing

7KFollowers

Pinned

U-M Rogel Cancer Center@UMRogelCancer · Mar 16

Big data, better cancer care; developing better drug therapies; nurturing high-risk, high-reward ideas. Read these stories and more #RogelResearch in our new issue of Illuminate magazine: rogelcancercenter.org/illuminate/iss…

UMRogelCancer's tweet image. Big data, better cancer care; developing better drug therapies; nurturing high-risk, high-reward ideas. Read these stories and more #RogelResearch in our new issue of Illuminate magazine: rogelcancercenter.org/illuminate/iss…

5.0K

U-M Rogel Cancer Center@UMRogelCancer · Jul 23

With support from Rogel's Forbes Institute for Cancer Discovery @NagrathSunitha and Max Wicha are working to ID which DCIS patients have potentially aggressive dormant cells at risk of becoming metastases: michmed.org/kVKbX @UMichChE #bcsm

UMRogelCancer's tweet image. With support from Rogel's Forbes Institute for Cancer Discovery @NagrathSunitha and Max Wicha are working to ID which DCIS patients have potentially aggressive dormant cells at risk of becoming metastases: michmed.org/kVKbX @UMichChE #bcsm

221

U-M Rogel Cancer Center@UMRogelCancer · Jul 19

"While it's really exciting when your drug goes into patients ... we must never forget that these patients are waiting for the next available treatment. That's what motivates me," says Judith Sebolt-Leopold in our Illuminate magazine story: michmed.org/nVk2d

UMRogelCancer's tweet image. "While it's really exciting when your drug goes into patients ... we must never forget that these patients are waiting for the next available treatment. That's what motivates me," says Judith Sebolt-Leopold in our Illuminate magazine story: michmed.org/nVk2d

126

U-M Rogel Cancer Center@UMRogelCancer · Jul 17

For 25 years, @AlexsLemonade has funded over 1,500 cutting-edge research projects at 150 institutions across North America and Europe. This year, Siva Kumar Natarajan from U-M has received a Young Investigator Grant for his work on ependymomas! 🎉 🔗michmed.org/WXPWq

UMRogelCancer's tweet image. For 25 years, @AlexsLemonade has funded over 1,500 cutting-edge research projects at 150 institutions across North America and Europe. This year, Siva Kumar Natarajan from U-M has received a Young Investigator Grant for his work on ependymomas! 🎉

🔗michmed.org/WXPWq

703

U-M Rogel Cancer Center@UMRogelCancer · Jul 17

What is an oncologist’s legacy? Dr. Daniel Hayes says it’s not creating a cure (although he has done much to advance cancer research). Listen to our conversation with 4 @umichmedicine leaders and former @ASCO presidents: youtube.com/watch?v=FmXxpe…

199

U-M Rogel Cancer Center@UMRogelCancer · Jul 16

Congrats to @LyssiotisLab who received inaugural award from @sgpcri aimed at transforming the understanding, early detection and treatment of pancreatic cancer: michmed.org/rwVDK @UMICHpancreas

UMRogelCancer's tweet image. Congrats to @LyssiotisLab who received inaugural award from @sgpcri aimed at transforming the understanding, early detection and treatment of pancreatic cancer: michmed.org/rwVDK @UMICHpancreas

2.0K

U-M Rogel Cancer Center@UMRogelCancer · Jul 15

Prostate cancer patients who have extreme non-response to androgen receptor inhibitors get significant benefit from docetaxel, suggesting potential for earlier docetaxel in this subset, new study from @AlumkalJoshi finds: michmed.org/gVrAB

UMRogelCancer's tweet image. Prostate cancer patients who have extreme non-response to androgen receptor inhibitors get significant benefit from docetaxel, suggesting potential for earlier docetaxel in this subset, new study from @AlumkalJoshi finds: michmed.org/gVrAB

184

U-M Rogel Cancer Center@UMRogelCancer · Jul 15

We're excited that @lynnhenrymd has been named our new associate director for community outreach and engagement. She'll work with our partners to address the cancer burden in Michigan: michmed.org/xryBB

UMRogelCancer's tweet image. We're excited that @lynnhenrymd has been named our new associate director for community outreach and engagement. She'll work with our partners to address the cancer burden in Michigan: michmed.org/xryBB

229

U-M Rogel Cancer Center@UMRogelCancer · Jul 14

What is the special sauce of @umich? Dr. Lori Pierce says the university’s collaborative environment has fueled our leadership in @ASCO. Listen to the full conversation: youtube.com/watch?v=FmXxpe… @UMichRadOnc

223

U-M Rogel Cancer Center@UMRogelCancer · Jul 13

The convergence of gymnastics, engineering and colorectal cancer surgery inspires Calista Harbaugh's work to translate new scientific principles to patient care: michmed.org/jVNRV @UM_IHPI @UMichSurgery #crcsm

UMRogelCancer's tweet image. The convergence of gymnastics, engineering and colorectal cancer surgery inspires Calista Harbaugh's work to translate new scientific principles to patient care: michmed.org/jVNRV @UM_IHPI @UMichSurgery #crcsm

356

U-M Rogel Cancer Center@UMRogelCancer · Jul 11

Researchers from @AlumkalJoshi lab used RNA seq data & clinical outcomes from prostate cancer clinical trial datasets to identify a gene program linked to androgen receptor inhibitor extreme non-response: michmed.org/gVrAB

UMRogelCancer's tweet image. Researchers from @AlumkalJoshi lab used RNA seq data &amp; clinical outcomes from prostate cancer clinical trial datasets to identify a gene program linked to androgen receptor inhibitor extreme non-response: michmed.org/gVrAB

142

U-M Rogel Cancer Center@UMRogelCancer · Jul 10

New study from @AlumkalJoshi lab identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment. Read the paper in @Nature_NPJ Precision Oncology: nature.com/articles/s4169… Read our summary: michmed.org/gVrAB

UMRogelCancer's tweet image. New study from @AlumkalJoshi lab identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment.

Read the paper in @Nature_NPJ Precision Oncology: nature.com/articles/s4169…
Read our summary: michmed.org/gVrAB

422

U-M Rogel Cancer Center Retweeted

Michigan Chemical Engineering@UMichChE · Jun 30

New funding supports research that could prevent long-term breast cancer metastases. ChE Prof. @NagrathSunitha has received funding from the @UMRogelCancer to lead innovative research using microfluidic assays and implantable scaffolds. Read more: michiganche.info/4iX1gQ1

335

U-M Rogel Cancer Center Retweeted

Matthew Pianko, MD@mpianko · Jul 2

🩸 Hem/Onc physicians, including community practitioners, fellows & faculty — join us for the Fall 2025 Hematologic Malignancies Symposium at @UMichMedicine! 📅 Sat, Oct 11 | ⏰ 9 AM–3:30 PM 📍 The Kensington Hotel, Ann Arbor, MI 💵 No cost to attend 💡 Focus on myeloma,…

309

U-M Rogel Cancer Center@UMRogelCancer · Jul 9

Dan Hertz @UMichPharmacy is using algorithms trained on large datasets of genetic data and chemotherapy dose levels to predict individualized toxicity levels, with a goal of decreasing the risk of a severe reaction to treatment: michmed.org/Q9PW9

UMRogelCancer's tweet image. Dan Hertz @UMichPharmacy is using algorithms trained on large datasets of genetic data and chemotherapy dose levels to predict individualized toxicity levels, with a goal of decreasing the risk of a severe reaction to treatment: michmed.org/Q9PW9

436

U-M Rogel Cancer Center@UMRogelCancer · Jul 8

Rogel has had 4 faculty serve as @ASCO president. Listen to Allen Lichter, Doug Blayney, Dan Hayes and Lori Pierce talk about their leadership and impact on cancer care and research: youtube.com/watch?v=FmXxpe…

520

U-M Rogel Cancer Center@UMRogelCancer · Jul 7

A study from #RogelCancer researchers @ArulChinnaiyan and @abhijitparolia, published in @ScienceMagazine, sheds light on how mutations in the FOXA1 gene—commonly altered in prostate cancer—drive tumor initiation formation and therapeutic resistance. michmed.org/XWArW

UMRogelCancer's tweet image. A study from #RogelCancer researchers @ArulChinnaiyan and @abhijitparolia, published in @ScienceMagazine, sheds light on how mutations in the FOXA1 gene—commonly altered in prostate cancer—drive tumor initiation formation and therapeutic resistance.

michmed.org/XWArW

701

U-M Rogel Cancer Center@UMRogelCancer · Jul 2

180

U-M Rogel Cancer Center@UMRogelCancer · Jun 30

327

U-M Rogel Cancer Center@UMRogelCancer · Jun 28

Examining how everyday exposures to preservatives in food or chemicals in personal care products can impact chronic disease processes, @justincolacino notes it's all about awareness and making informed choices about what we use: michmed.org/3GKjx @umichsph

UMRogelCancer's tweet image. Examining how everyday exposures to preservatives in food or chemicals in personal care products can impact chronic disease processes, @justincolacino notes it's all about awareness and making informed choices about what we use: michmed.org/3GKjx @umichsph

173

U-M Rogel Cancer Center@UMRogelCancer · Jun 23

What is an oncologist’s legacy? Dr. Daniel Hayes says it’s not creating a cure (although he has done much to advance cancer research). Listen to the full conversation: youtube.com/watch?v=FmXxpe… @ASCO @UMIntMed @hoosierdfh

335